Basic Scientists, Industry and Clinicians: Are Three a Crowd? (Video)

The GP IIb/IIIa Inhibitor Abciximab (ReoPro((R))) Decreases Activation and Interaction of Platelets and Leukocytes During In Vitro Cardiopulmonary Bypass Simulation

The aim of this study was to investigate the effect of the GP IIb/IIIa inhibitor abciximab (ReoPro((R))) on the function and interaction of platelets and leukocytes during experimental CPB.